Literature DB >> 11727871

Ocular signs of systemic hypertension: a review.

P G Hurcomb1, J S Wolffsohn, G A Napper.   

Abstract

Cardiovascular disease and stroke continue to be the chief causes of death in developed countries and one of the leading causes of visual impairment. The individual with systemic hypertension may remain asymptomatic for many years. Systemic mortality and morbidity are markedly higher for hypertensives than normotensives, but can be significantly reduced by early diagnosis and then efficient management. However, the ability of Optometrists to detect and appropriately refer systemic hypertensives remains generally poor. This review examines the disease, its effects and detection by observation of the retinal signs, particularly those considered to be pre-malignant. Previous methods of classifying retinal hypertensive signs are discussed along with more recent image analysis techniques. The role of the optometrist in detecting, monitoring and appropriate referral of systemic hypertensives is discussed in relation to current research.

Entities:  

Mesh:

Year:  2001        PMID: 11727871     DOI: 10.1046/j.1475-1313.2001.00617.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  3 in total

Review 1.  Hypertension and the eye.

Authors:  James S Wolffsohn; Peter G Hurcomb
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Effectiveness of in-office blood pressure measurement by eye care practitioners in early detection and management of hypertension.

Authors:  Saud A AlAnazi; Uchechukwu L Osuagwu; Turki M AlMubrad; Hany K Ahmed; Kelechi C Ogbuehi
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Noninvasive Assessment of Retinal Blood Flow Using a Novel Handheld Laser Speckle Contrast Imager.

Authors:  Abhishek Rege; Samantha I Cunningham; Yusi Liu; Karan Raje; Sachin Kalarn; M Jason Brooke; Lisa Schocket; Sunni Scott; Asifa Shafi; Luis Toledo; Osamah J Saeedi
Journal:  Transl Vis Sci Technol       Date:  2018-11-14       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.